about
Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis.Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry.Cardiac indexes, cardiac damage biomarkers and energy expenditure in professional cyclists during the Giro d'Italia 3-weeks stage race.Levels of human erythrocyte membrane-bound and cytosolic glycohydrolases are associated with oxidative stress in erectile dysfunction patientsA multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial.T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosisEvaluation of high sensitive troponin in erectile dysfunction.IL-18 level in patients undergoing coronary artery bypass grafting surgery or valve replacement: which link with epicardial fat depot?Osteocartilaginous metabolic markers change over a 3-week stage race in pro-cyclists.Vitamin D Deficiency Is Associated with Increased Osteocalcin Levels in Acute Aortic Dissection: A Pilot Study on Elderly Patients.Changes in urinary amino acids excretion in relationship with muscle activity markers over a professional cycling stage race: in search of fatigue markers.Occupational exposure to zoonotic agents among agricultural workers in Lombardy Region, northern Italy.Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV coinfection, receiving boosted or unboosted regimens.Changes in lipid profile in response to three different protocols of whole-body cryostimulation treatments.Evaluation of microalbuminuria in patients with erectile dysfunction.The role of inflammation in patients with intraductal mucinous neoplasm of the pancreas and in those with pancreatic adenocarcinoma.Plasma myeloperoxidase in patients with erectile dysfunction of arteriogenic- and non-arteriogenic origin: association with markers of endothelial dysfunction.Comment on: Adipokines, hormonal parameters, and cardiovascular risk factors: similarities and differences between patients with erectile dysfunction of arteriogenic and nonarteriogenic origin.Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?Comparison of three strategies for myocardial protection during coronary artery bypass graft surgery based on markers of cardiac damage.Time course of proadrenomedullin in the early phase of septic shock. A comparative study with other proinflammatory proteins.Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device.Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide.Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury.The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis.Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections?Serum markers of myocardial damage in acute pancreatitis: a prospective time course study.NT-proBNP concentrations in mountain marathoners.Intra-operative testing for parathyroid hormone: the Central Laboratory option.Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.Effects of the whole-body cryotherapy on NTproBNP, hsCRP and troponin I in athletes.Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.Early retinol-binding protein levels are associated with growth changes in infants born to diabetic mothers.Limitations of Cockcroft-Gault and MDRD formulas in estimating GFR among top-level rugby players.Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.Evaluation of the performance of a new OptiScanner™ 5000 system for an intermittent glucose monitoring.Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different etiology.Is the pancreas affected in patients with septic shock?--a prospective study.Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot studySerum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms
P50
Q33308826-CC7BADF8-E736-480A-95EE-8CBB98259BF4Q33676621-330C841A-8AE3-4FF9-AF8E-0E4867E99C55Q33773211-05DC396E-EE41-46AE-B3AF-CBE1631C9664Q34064803-C8BF4E92-A665-491B-9AAF-C35306EC608EQ34286688-E0BD4E84-C07B-4774-82F3-4176DE10D47BQ34430776-C166ED37-8D78-4821-ADE9-3315031B111DQ35557509-18C50BC6-743E-4E00-B3D0-461951842732Q39489654-693A829D-F855-423F-B4D1-C25886C335E1Q40736462-D50B14F2-F48F-44B8-B397-E777684AA7FAQ41022799-AA9CD098-94A0-473C-BCF7-CB9035A96EBFQ41452841-422DEDFE-1C5B-4040-9B5B-CEB02F0536A1Q42247494-7FEDF37E-27E2-456D-911E-BA3D05F2AC01Q43036513-69DD9B4A-3DF1-42ED-A817-51AF0D449EABQ43102702-EA1B95EA-34CE-4733-B6C7-61F69B071C06Q43268619-FE056742-326F-404B-8531-D9C510536238Q43474144-CB0BB9E8-086F-4935-8645-5C587822B581Q43637395-97B341D6-FCE9-4F02-B50F-C0C52E397E47Q44593050-9A8D41CC-95B7-4B78-AF90-8ABD29CA249FQ45989287-EA490D9F-1106-46E1-8D0F-2A459236192DQ46483103-6653E2E6-B4B0-4FD8-A9F8-307898F87B04Q46548433-DB6D0DC9-7392-4B7D-9735-279639D6B925Q46874304-38F30F9F-397B-4EC5-BAA3-1EFFC940F976Q46883455-85107FF6-95A6-4D21-B061-73A9A6DC6F52Q47779846-3918DB8E-0A49-4D36-82C4-C16C71B1E28DQ48121592-4F649A23-14B2-4A26-B109-AAA6A25C5D67Q48130190-E04A25E1-1AC9-4B65-80FA-91D6D1171135Q48230663-F529EB56-F612-404F-99F7-58C031535D3CQ48236599-7B4F85D0-0FFE-41CE-BCE8-68EF5B680241Q48515538-B7C972CD-F8AF-4061-8938-27DDAA6FC87AQ48535852-46BC4061-94B2-4F59-87F8-DB0E6590442AQ48894261-4688726E-D03B-4125-84A0-3F3B9990FCF9Q50126179-D27B30E0-1641-42AE-BF21-16C0C4A609BCQ51321844-E6C0CC15-744C-4107-9872-89071AE1D737Q51416094-9CCBABBA-34D1-407E-AFCD-0C8D10DCDC2EQ51702092-F25D7D70-869C-4DA0-8CCB-13FD3AB11D76Q53084184-705A5001-6BA9-4560-B650-C50042A8CC1CQ54208968-691E08B6-9895-4192-9321-39725ECD18EDQ54677429-BE105906-E814-4A8F-A336-C83A03309FF0Q56985539-A8766711-94A5-4FBC-8383-E68142CF702AQ56989560-0C84A063-BFA2-4FCF-BBF7-C2A4D231371D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alessandra Barassi
@ast
Alessandra Barassi
@en
Alessandra Barassi
@es
Alessandra Barassi
@nl
type
label
Alessandra Barassi
@ast
Alessandra Barassi
@en
Alessandra Barassi
@es
Alessandra Barassi
@nl
prefLabel
Alessandra Barassi
@ast
Alessandra Barassi
@en
Alessandra Barassi
@es
Alessandra Barassi
@nl
P106
P21
P31
P496
0000-0002-0404-8357